Corbus Pharmaceuticals Holdings - 53 Year Dividend History | CRBP
Historical dividend payout and yield for Corbus Pharmaceuticals Holdings (CRBP) since 1971. The current TTM dividend payout for Corbus Pharmaceuticals Holdings (CRBP) as of November 20, 2024 is $0.00. The current dividend yield for Corbus Pharmaceuticals Holdings as of November 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.204B |
$0.001B |
|
Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
